Neuraxis, inc. issues letter to shareholders from brian carrico, president and chief executive officer

Carmel, ind., dec. 20, 2023 (globe newswire) -- neuraxis, inc. (nyse american: nrxs) (“neuraxis” or the “company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today issued a letter to its shareholders.
NRXS Ratings Summary
NRXS Quant Ranking